Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation

Tong Hong Wang, Chi Hao Wu, Chau Ting Yeh, Shih Chi Su, Shih Min Hsia, Kung Hao Liang, Chin Chuan Chen, Chuen Hsueh, Chi Yuan Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Melatonin is the primary pineal hormone that relays light/dark cycle information to the circadian system. It was recently reported to exert intrinsic antitumor activity in various cancers. However, the regulatory mechanisms underlying the antitumor activity of melatonin are poorly understood. Moreover, a limited number of studies have addressed the role of melatonin in hepatocellular carcinoma (HCC), a major life-threatening malignancy in both sexes in Taiwan. In this study, we investigated the antitumor effects of melatonin in HCC and explored the regulatory mechanisms underlying these effects. We observed that melatonin significantly inhibited the proliferation, migration, and invasion of HCC cells and significantly induced the expression of the transcription factor FOXA2 in HCC cells. This increase in FOXA2 expression resulted in upregulation of lncRNA-CPS1 intronic transcript 1 (CPS1- IT1), which reduced HIF-1α activity and consequently resulted in the suppression of epithelial-mesenchymal transition (EMT) progression and HCC metastasis. Furthermore, the results of the in vivo experiments confirmed that melatonin exerts tumor suppressive effects by reducing tumor growth. In conclusion, our findings suggested that melatonin inhibited HCC progression by reducing lncRNA-CPS1- IT1-mediated EMT suppression and indicated that melatonin could be a promising treatment for HCC.

Original languageEnglish
Pages (from-to)82280-82293
Number of pages14
JournalOncotarget
Volume8
Issue number47
DOIs
Publication statusPublished - 2017

Fingerprint

Long Noncoding RNA
Melatonin
Hepatocellular Carcinoma
Epithelial-Mesenchymal Transition
Neoplasms
Photoperiod
Taiwan
Transcription Factors
Up-Regulation
Hormones
Neoplasm Metastasis

Keywords

  • Epithelial-mesenchymal transition
  • Hepatocellular carcinoma
  • HIF-1α
  • LncRNA-CPS1-IT1
  • melatonin

ASJC Scopus subject areas

  • Oncology

Cite this

Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation. / Wang, Tong Hong; Wu, Chi Hao; Yeh, Chau Ting; Su, Shih Chi; Hsia, Shih Min; Liang, Kung Hao; Chen, Chin Chuan; Hsueh, Chuen; Chen, Chi Yuan.

In: Oncotarget, Vol. 8, No. 47, 2017, p. 82280-82293.

Research output: Contribution to journalArticle

Wang, TH, Wu, CH, Yeh, CT, Su, SC, Hsia, SM, Liang, KH, Chen, CC, Hsueh, C & Chen, CY 2017, 'Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation', Oncotarget, vol. 8, no. 47, pp. 82280-82293. https://doi.org/10.18632/oncotarget.19316
Wang, Tong Hong ; Wu, Chi Hao ; Yeh, Chau Ting ; Su, Shih Chi ; Hsia, Shih Min ; Liang, Kung Hao ; Chen, Chin Chuan ; Hsueh, Chuen ; Chen, Chi Yuan. / Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation. In: Oncotarget. 2017 ; Vol. 8, No. 47. pp. 82280-82293.
@article{9c87013f31b84f6299511170f1bc7af5,
title = "Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation",
abstract = "Melatonin is the primary pineal hormone that relays light/dark cycle information to the circadian system. It was recently reported to exert intrinsic antitumor activity in various cancers. However, the regulatory mechanisms underlying the antitumor activity of melatonin are poorly understood. Moreover, a limited number of studies have addressed the role of melatonin in hepatocellular carcinoma (HCC), a major life-threatening malignancy in both sexes in Taiwan. In this study, we investigated the antitumor effects of melatonin in HCC and explored the regulatory mechanisms underlying these effects. We observed that melatonin significantly inhibited the proliferation, migration, and invasion of HCC cells and significantly induced the expression of the transcription factor FOXA2 in HCC cells. This increase in FOXA2 expression resulted in upregulation of lncRNA-CPS1 intronic transcript 1 (CPS1- IT1), which reduced HIF-1α activity and consequently resulted in the suppression of epithelial-mesenchymal transition (EMT) progression and HCC metastasis. Furthermore, the results of the in vivo experiments confirmed that melatonin exerts tumor suppressive effects by reducing tumor growth. In conclusion, our findings suggested that melatonin inhibited HCC progression by reducing lncRNA-CPS1- IT1-mediated EMT suppression and indicated that melatonin could be a promising treatment for HCC.",
keywords = "Epithelial-mesenchymal transition, Hepatocellular carcinoma, HIF-1α, LncRNA-CPS1-IT1, melatonin",
author = "Wang, {Tong Hong} and Wu, {Chi Hao} and Yeh, {Chau Ting} and Su, {Shih Chi} and Hsia, {Shih Min} and Liang, {Kung Hao} and Chen, {Chin Chuan} and Chuen Hsueh and Chen, {Chi Yuan}",
year = "2017",
doi = "10.18632/oncotarget.19316",
language = "English",
volume = "8",
pages = "82280--82293",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "47",

}

TY - JOUR

T1 - Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation

AU - Wang, Tong Hong

AU - Wu, Chi Hao

AU - Yeh, Chau Ting

AU - Su, Shih Chi

AU - Hsia, Shih Min

AU - Liang, Kung Hao

AU - Chen, Chin Chuan

AU - Hsueh, Chuen

AU - Chen, Chi Yuan

PY - 2017

Y1 - 2017

N2 - Melatonin is the primary pineal hormone that relays light/dark cycle information to the circadian system. It was recently reported to exert intrinsic antitumor activity in various cancers. However, the regulatory mechanisms underlying the antitumor activity of melatonin are poorly understood. Moreover, a limited number of studies have addressed the role of melatonin in hepatocellular carcinoma (HCC), a major life-threatening malignancy in both sexes in Taiwan. In this study, we investigated the antitumor effects of melatonin in HCC and explored the regulatory mechanisms underlying these effects. We observed that melatonin significantly inhibited the proliferation, migration, and invasion of HCC cells and significantly induced the expression of the transcription factor FOXA2 in HCC cells. This increase in FOXA2 expression resulted in upregulation of lncRNA-CPS1 intronic transcript 1 (CPS1- IT1), which reduced HIF-1α activity and consequently resulted in the suppression of epithelial-mesenchymal transition (EMT) progression and HCC metastasis. Furthermore, the results of the in vivo experiments confirmed that melatonin exerts tumor suppressive effects by reducing tumor growth. In conclusion, our findings suggested that melatonin inhibited HCC progression by reducing lncRNA-CPS1- IT1-mediated EMT suppression and indicated that melatonin could be a promising treatment for HCC.

AB - Melatonin is the primary pineal hormone that relays light/dark cycle information to the circadian system. It was recently reported to exert intrinsic antitumor activity in various cancers. However, the regulatory mechanisms underlying the antitumor activity of melatonin are poorly understood. Moreover, a limited number of studies have addressed the role of melatonin in hepatocellular carcinoma (HCC), a major life-threatening malignancy in both sexes in Taiwan. In this study, we investigated the antitumor effects of melatonin in HCC and explored the regulatory mechanisms underlying these effects. We observed that melatonin significantly inhibited the proliferation, migration, and invasion of HCC cells and significantly induced the expression of the transcription factor FOXA2 in HCC cells. This increase in FOXA2 expression resulted in upregulation of lncRNA-CPS1 intronic transcript 1 (CPS1- IT1), which reduced HIF-1α activity and consequently resulted in the suppression of epithelial-mesenchymal transition (EMT) progression and HCC metastasis. Furthermore, the results of the in vivo experiments confirmed that melatonin exerts tumor suppressive effects by reducing tumor growth. In conclusion, our findings suggested that melatonin inhibited HCC progression by reducing lncRNA-CPS1- IT1-mediated EMT suppression and indicated that melatonin could be a promising treatment for HCC.

KW - Epithelial-mesenchymal transition

KW - Hepatocellular carcinoma

KW - HIF-1α

KW - LncRNA-CPS1-IT1

KW - melatonin

UR - http://www.scopus.com/inward/record.url?scp=85030855045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030855045&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.19316

DO - 10.18632/oncotarget.19316

M3 - Article

AN - SCOPUS:85030855045

VL - 8

SP - 82280

EP - 82293

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 47

ER -